These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7153093)

  • 41. Radiotherapy dose-fractionation schedules. Hyperfractionation and accelerated treatment regimens.
    Freeman CR; Lehnert S
    Neurol Clin; 1991 May; 9(2):351-62. PubMed ID: 1944104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization of the time-dose relationship.
    Peschel RE; Fischer JJ
    Semin Oncol; 1981 Mar; 8(1):38-48. PubMed ID: 7244664
    [No Abstract]   [Full Text] [Related]  

  • 43. Relationship between the generalized equivalent uniform dose formulation and the Poisson statistics-based tumor control probability model.
    Zhou SM; Das S; Wang Z; Marks LB
    Med Phys; 2004 Sep; 31(9):2606-9. PubMed ID: 15487743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analytical investigation of the possibility of parameter invariant TCP-based radiation therapy plan ranking.
    Stavreva N; Nahum A; Markov K; Ruggieri R; Stavrev P
    Acta Oncol; 2010 Nov; 49(8):1324-33. PubMed ID: 20950227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular response to low-dose irradiation.
    Short SC; Joiner MC
    Clin Oncol (R Coll Radiol); 1998; 10(2):73-7. PubMed ID: 9610894
    [No Abstract]   [Full Text] [Related]  

  • 46. Rationale for fractionated radiotherapy.
    Kimler BF; Oliver LM
    Radiol Technol; 1980; 51(6):809-14. PubMed ID: 7413963
    [No Abstract]   [Full Text] [Related]  

  • 47. The EORTC hyperfractionation trial.
    Withers HR
    Radiother Oncol; 1992 Dec; 25(4):229-30. PubMed ID: 1480767
    [No Abstract]   [Full Text] [Related]  

  • 48. The first James Kirk memorial lecture. What next in fractionated radiotherapy?
    Fowler JF
    Br J Cancer Suppl; 1984; 6():285-300. PubMed ID: 6365141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A mathematical model for assessing permissible dose fractions].
    Ivanov VK
    Radiobiol Radiother (Berl); 1986; 27(6):747-51. PubMed ID: 3575682
    [No Abstract]   [Full Text] [Related]  

  • 50. Volume and time factors in interstitial gamma-ray therapy.
    Barkley HT; Fletcher GH
    AJR Am J Roentgenol; 1976 Jan; 126(1):163-70. PubMed ID: 175676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Radiobiological principles of the choice of dose fractionation in the radiotherapy of tumors].
    Akimov AA; Kozlov AP
    Med Radiol (Mosk); 1987 Jul; 32(7):81-6. PubMed ID: 3302586
    [No Abstract]   [Full Text] [Related]  

  • 52. Radiotargeting agents for cancer therapy.
    Kassis AI
    Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose response curves for organ function or cell survival.
    Fowler JF
    Br J Radiol; 1983 Jul; 56(667):497-500. PubMed ID: 6860900
    [No Abstract]   [Full Text] [Related]  

  • 55. [Problems concerning fractionated radiotherapy (2). Time-dosage distribution in relation to the repair of potentially lethal damage and repopuration of cancer cells].
    Urano M
    Rinsho Hoshasen; 1976 Oct; 21(11):1015-6. PubMed ID: 1034060
    [No Abstract]   [Full Text] [Related]  

  • 56. NSD and cell survival.
    Lokajícek M; Kozubek S; Prokes K
    Br J Radiol; 1979 Jul; 52(619):571-2. PubMed ID: 465942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of mathematical optimization in radiation therapy for finding optimum irradiation techniques (author's transl)].
    Franke DS
    Radiobiol Radiother (Berl); 1980 Oct; 21(5):668-76. PubMed ID: 7208855
    [No Abstract]   [Full Text] [Related]  

  • 58. [Importance of the value of the dose fraction and the time factor in radiation therapy].
    Zholkiver KI
    Med Radiol (Mosk); 1986 Mar; 31(3):72-9. PubMed ID: 3515108
    [No Abstract]   [Full Text] [Related]  

  • 59. [Role and methods of radiotherapy in the treatment of malignant melanoma].
    Delaunay MM; Maire JP
    Ann Dermatol Venereol; 1991; 118(5):393-400. PubMed ID: 1897823
    [No Abstract]   [Full Text] [Related]  

  • 60. [Radiobiological rationale of neutron radiotherapy].
    Masuda K; Aramaki R; Sasaki H; Cho T; Yoshinaga H
    Fukuoka Igaku Zasshi; 1986 Dec; 77(12):641-50. PubMed ID: 3549497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.